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Sickle Cell Data
Collection Program Brief:
Births in Georgia, 2004-2016
May 2019
The Sickle Cell Data Collection (SCDC) program collects health information about people with sickle cell
disease (SCD) to study trends in diagnosis, treatment, and health care utilization in the United States. Georgia
is one of two states currently participating in this Centers for Disease Control and Prevention initiative.
This brief is part of a series produced using SCDC Georgia data that can inform decision-makers about how
critical gaps in diagnosis, treatment, and access to care for patients with SCD can be filled through policy
changes, improved health care practices, and education. This brief focuses on the number of new cases of
SCD identified between 2004 and 2016 through the state’s newborn screening program. Geography greatly
impacts access to specialized SCD care. Understanding the distribution of SCD births can inform questions
related to access, health care utilization, and quality of care during childhood.

How Is Sickle Cell Disease Diagnosed?
SCD is diagnosed with a blood test. Since early diagnosis and treatment are important, SCD is most often
diagnosed at birth during routine newborn screening at the hospital, as required in every state. Follow-up
testing confirms SCD and can identify which specific genetic form of SCD a patient has.
If a newborn has a positive hemoglobin screening result, the American Academy of Pediatrics recommends
confirmatory testing by 3 months of age. In Georgia, the newborn screening program is run by the Georgia
Department of Public Health, including initial testing and oversight of follow-up programs. For follow-up of
positive results, the newborn screening program contracts with Children’s Healthcare of Atlanta for newborns
with positive test results in the Metro Atlanta counties, while Augusta University provides follow-up for all other
counties in the state.
The teams report abnormal results to parents and the health care provider listed at birth, ensure timely
confirmatory testing, and provide education and counseling to families. Confirmatory testing and additional
testing of other family members for blood disorders are provided free of charge. Confirmed cases are referred
to the Children 1st program at the Georgia Department of Public Health for determination of eligibility for
child health intervention services.
Georgia newborn screening records do not capture individuals who move to Georgia from another state or
country or individuals born with SCD in the state before implementation of universal screening in 1998.
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New Cases of Sickle Cell Disease in Georgia
Figure 1: SCD Births in Georgia by Year, 2004-2016
Georgia’s newest SCDC data shows that
approximately 155 babies with SCD are born in
the state each year, with rates staying relatively
constant from year to year from 2004 through
2016 (Figure 1). Over 95% of babies born with
SCD in Georgia are black or African-American,
meaning that one out of approximately every 295
black or African-American babies born in Georgia
from 2004 through 2016 has SCD.

As the map shows in Figure 2, babies with
SCD are born in almost every county throughout
Georgia. However, they are not evenly distributed
throughout the state. Five Metro Atlanta counties
averaged more than 10 SCD births each year, while 100 counties saw from one to 12 total SCD births over the
13-year period.

Why Is Geography Important?
SCDC data shows where patients, health care providers,
and health care facilities are geographically located and
can help answer questions related to access, health care
utilization, and quality of care.

Figure 2: SCD Births in Georgia 2004-2016 by County
of Residence (N = 2,019*), with Locations of Sickle Cell
Specialty Care

By overlaying SCD births in the state with pediatric SCD
treatment centers, SCDC data highlights geographic
challenges in gaining access to care, how far patients
travel for treatment, whether they are seen at the closest
facilities to their home, the ratio of identified patients to
services or providers in a given region, and how these
geographical factors may influence utilization by provider
type (e.g., emergency department).
For instance, there were 60 SCD births in Muscogee
County (where Columbus is the county seat) from 2004
to 2016. But the Columbus area is nearly a two-hour
drive to the pediatric comprehensive SCD treatment
center in Atlanta and a four-hour drive to the pediatric
comprehensive SCD treatment center in Augusta. To
better serve SCD patients in the Columbus area, the
Aflac Cancer and Blood Disorders Center of Children’s
Healthcare of Atlanta opened an outpatient clinic in
Columbus, with funding from the Piedmont Columbus
Regional Foundation in March 2019.

*Thirteen births during this period lack addresses and are not represented
in the map.

At the time of writing, there are two comprehensive pediatric SCD programs in the state, with five associated
pediatric outreach clinics in middle and south Georgia. There are two additional pediatric SCD treatment
centers in Macon and Savannah, with plans in progress to increase outreach through specialized community
health workers in several areas.

Connect with SCDC

SCDC nationally: www.cdc.gov/ncbddd/hemoglobinopathies/scdc.html
SCDC Georgia: www.ghpc.gsu.edu/project/hemoglobin-disorders-data-coordinating-center
Contact Angela B. Snyder (angiesnyder@gsu.edu) if you would like to use SCDC Georgia data for your
research or planning.

